1. Home
  2. INDP vs BAOS Comparison

INDP vs BAOS Comparison

Compare INDP & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$3.70

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

BAOS

Baosheng Media Group Holdings

HOLD

Current Price

$3.03

Market Cap

4.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDP
BAOS
Founded
2000
2018
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
4.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
INDP
BAOS
Price
$3.70
$3.03
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.5M
76.5K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$1.98
52 Week High
$13.24
$5.40

Technical Indicators

Market Signals
Indicator
INDP
BAOS
Relative Strength Index (RSI) 61.21 53.32
Support Level $1.86 $2.45
Resistance Level $3.84 $3.64
Average True Range (ATR) 0.90 0.37
MACD 0.19 0.01
Stochastic Oscillator 56.56 43.05

Price Performance

Historical Comparison
INDP
BAOS

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd is a China-based online marketing solution provider. The company provides internet marketing, short-video and V-log marketing, content production and operation, e-commerce marketing, data platform services, and AI technology-related services. It also offers customized marketing solutions and channel marketing services through partnerships with internet platforms such as Tencent, Alibaba, ByteDance, and Kuaishou.

Share on Social Networks: